MetaCap

Coherus Oncology (CHRS) News

NASDAQ: CHRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.3698-0.0173 (-4.47%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CHRS news summary

We found 10 recent headlines mentioning Coherus Oncology (CHRS): 0 in the past week and 9 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, CHRS is down 4.47% at $0.3698. The most recent story, "Weekly Buzz: LLY, JNJ Win FDA Nod; SION, NNOX, Cut Jobs; PFE, ARGX Strike Deals", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Coherus Oncology headlines

Stocks mentioned alongside CHRS

Compare CHRS